Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

BONE, Inc. (NASDAQ:SIBN), recently sold shares of the company's common stock. The medical device company, currently valued at approximately $754 million, has shown strong momentum with a nearly 29% ...

https://www.tipranks.com/news/the-fly/pepgen-price-target-lowered-to-16-from-26-at-h-c-wainwright Needham raised the firm’s price target on SI-Bone (SIBN) to $20 ...

Fintel reports that on February 7, 2025, Alliance Global Partners initiated coverage of Quantum-Si (NasdaqGM:QSI) with a Buy ...

These ratings convey the analysts' expectations for the relative performance of Quantum-Si compared to the broader market. Price Targets: Analysts gauge the dynamics of price targets, providing ...

Stifel raised the firm’s price target on SiTime (SITM) to $270 from $250 and keeps a Buy rating on the shares after a December quarter beat and ...

--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq ... and sale of 15,625,000 shares of common stock at a purchase price of $3.20 per share, pursuant to a registered direct offering, resulting ...

Observing a 6.67% increase, the current average has risen from the previous average price target of $3.75. The analysis of recent analyst actions sheds light on the perception of Quantum-Si by ...